tirzepatide launch date Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity FDA approves tirzepatide, Eli Lilly's

Lancet 381 , 19051915 (2013)

In December 2025, the administration also introduced the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) model, a five year CMS Innovation Center (CMMI) model that intends to expand access to obesity drugs in Medicaid and Medicare by negotiating lower GLP-1 prices with manufacturers

Notably, this effect of rifaximin was based on the modulation of the gut-liver-muscle axis through the suppression of the endogenous LPS overload by maintaining intestinal barrier function, in addition to its ammonia-lowering properties

Collagen is a type of protein found in the skin (types I and III collagen), joints (type II collagen) and other parts of the body

This hormone interacts with the brains appetite control centers, helping to curb hunger and reduce the desire for food